113 related articles for article (PubMed ID: 11719217)
21. Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors.
Boureux A; Furstoss O; Simon V; Roche S
J Cell Sci; 2005 Aug; 118(Pt 16):3717-26. PubMed ID: 16076903
[TBL] [Abstract][Full Text] [Related]
22. Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation.
Sini P; Cannas A; Koleske AJ; Di Fiore PP; Scita G
Nat Cell Biol; 2004 Mar; 6(3):268-74. PubMed ID: 15039778
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts.
Feshchenko EA; Shore SK; Tsygankov AY
Oncogene; 1999 Jun; 18(25):3703-15. PubMed ID: 10391678
[TBL] [Abstract][Full Text] [Related]
24. c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1.
Jehn BM; Dittert I; Beyer S; von der Mark K; Bielke W
J Biol Chem; 2002 Mar; 277(10):8033-40. PubMed ID: 11777909
[TBL] [Abstract][Full Text] [Related]
25. Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1.
Sanguinetti AR; Cao H; Corley Mastick C
Biochem J; 2003 Nov; 376(Pt 1):159-68. PubMed ID: 12921535
[TBL] [Abstract][Full Text] [Related]
26. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
Liu J; Wu Y; Arlinghaus RB
Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
[TBL] [Abstract][Full Text] [Related]
27. Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation.
Liu X; Huang W; Li C; Li P; Yuan J; Li X; Qiu XB; Ma Q; Cao C
Mol Cell; 2006 May; 22(3):317-27. PubMed ID: 16678104
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.
Janas JA; Van Aelst L
Mol Cell Biol; 2011 Jul; 31(13):2552-65. PubMed ID: 21536658
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-mediated degradation of active Src tyrosine kinase.
Harris KF; Shoji I; Cooper EM; Kumar S; Oda H; Howley PM
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13738-43. PubMed ID: 10570142
[TBL] [Abstract][Full Text] [Related]
30. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.
Hu H; Bliss JM; Wang Y; Colicelli J
Curr Biol; 2005 May; 15(9):815-23. PubMed ID: 15886098
[TBL] [Abstract][Full Text] [Related]
31. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
Feiková S; Wolff L; Bies J
Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
[TBL] [Abstract][Full Text] [Related]
32. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
[TBL] [Abstract][Full Text] [Related]
33. A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.
Okuda K; D'Andrea A; Etten RA; Griffin JD
J Clin Invest; 1997 Oct; 100(7):1708-15. PubMed ID: 9312168
[TBL] [Abstract][Full Text] [Related]
34. CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families.
Krisch LM; Posselt G; Hammerl P; Wessler S
Infect Immun; 2016 Sep; 84(9):2671-80. PubMed ID: 27382024
[TBL] [Abstract][Full Text] [Related]
35. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
Mayer BJ; Hirai H; Sakai R
Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Cellular Tyrosine Phosphorylation via Chemical Rescue of Conditionally Active Abl Kinase.
Wang Z; Kim MS; Martinez-Ferrando I; Koleske AJ; Pandey A; Cole PA
Biochemistry; 2018 Feb; 57(8):1390-1398. PubMed ID: 29341593
[TBL] [Abstract][Full Text] [Related]
37. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
[TBL] [Abstract][Full Text] [Related]
38. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
Van Etten RA; Debnath J; Zhou H; Casasnovas JM
Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
[TBL] [Abstract][Full Text] [Related]
39. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
40. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
